The Department of Defense (DOD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense Enabling Biotechnologies has awarded a contract valued at $27.3 million to Ology Bioservices, a biologics contract development and manufacturing organization (CDMO), to establish their proprietary Veroplex cell platform for rapid response to emerging viral diseases.   “The Veroplex platform has the possibility to allow rapid vaccine development for many potential emerging vir...